Can new approaches for deriving human stem cells circumnavigate existing patents that dominate embryonic stem cell intellectual property?
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Thomson, J.A. et al. Science 282, 1145–1147 (1998).
Wilmut, I. et al. Nature 386, 200 (1997).
US Patent Nos. 5,843,780 (December 1, 1998) and 6,200,806 (March 13, 2001).
US Patent No. 6,147,276 (November 4, 2000).
Rabin, S. Nat. Biotechnol. 23, 817–819 (2005).
Memorandum of understanding between WiCell Research Institute and Public Health Service, effective Sept. 5, 2001. <http://stemcells.nih.gov/staticresources/research/registry/MTAs/Wicell_MOU.pdf >
Vrana, K.E. et al. Proc. Natl. Acad. Sci. USA 100, 11911–11916 (2003).
Tomohiro K. Nature 428, 860–864 (2004).
Kuliev, A. & Verlinsky, Y. Am. J. Med. Genet. A. 134, 105–110 (2005).
Chung, Y. et al. Nature 439, 216–219 (2006).
Cowan, C.A. et al. Science 309, 1369–1373 (2005).
Meissner, A. & Jaenisch, R. Nature 439, 212–215 (2006).
Melton, D.A. et al. N. Engl. J. Med. 351, 2791–2792 (2004).
Kiessling, A. Connecticut Law Rev. 36, 1051–1092 (2004).
NIH. Stem cells: scientific progress and future research directions <http://stemcells.nih.gov/info/scireport/chapter2.asp> (2001).
Jaenisch R. N. Engl. J. Med. 351, 2787–2791 (2004).
Hochedlinger, K. & Jaenisch, R. N. Engl. J. Med. 349, 275–286 (2003).
Brambrink, T. et al. Proc. Natl. Acad. Sci. USA 103, 933–938 (2006).
US Patent Application No. 20050158854 (July 21, 2005).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Taymor, K., Scott, C. & Greely, H. The paths around stem cell intellectual property. Nat Biotechnol 24, 411–413 (2006). https://doi.org/10.1038/nbt0406-411
Issue Date:
DOI: https://doi.org/10.1038/nbt0406-411
This article is cited by
-
Patenting pluripotence: the next battle for stem cell intellectual property
Nature Biotechnology (2008)
-
The global stem cell patent landscape: implications for efficient technology transfer and commercial development
Nature Biotechnology (2007)
-
Research sharing, ethics and public benefit
Nature Biotechnology (2007)
-
Proposition 71 and CIRM—assessing the return on investment
Nature Biotechnology (2007)
-
Embryonic Stem Cell Patents and Human Dignity
Health Care Analysis (2007)